Michael Wiederhorn
Stock Analyst at Oppenheimer
(4.74)
# 677
Out of 4,673 analysts
1096
Total ratings
58.9%
Success rate
10.9%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCSG Healthcare Services Group | Initiated Coverage: Buy | $28 | $22.77 | +22.97% | 1 | Aug 19, 2026 | |
| PACS PACS Group | Maintained: Buy | $48 → $57 | $44.25 | +28.81% | 6 | Aug 10, 2026 | |
| EVH Evolent Health | Rated: Buy | $6 | $4.74 | +26.58% | 13 | Aug 7, 2026 | |
| GRDN Guardian Pharmacy Services | Maintained: Buy | $43 → $49 | $37.93 | +29.19% | 8 | Aug 7, 2026 | |
| TDOC Teladoc Health | Rated: Buy | $7 | $6.39 | +9.55% | 31 | Aug 4, 2026 | |
| CHE Chemed | Rated: Buy | $500 → $590 | $540.57 | +9.14% | 118 | Jul 31, 2026 | |
| HUM Humana | Rated: Buy | $260 → $405 | $378.88 | +6.89% | 80 | Jul 30, 2026 | |
| ENSG The Ensign Group | Maintained: Buy | $210 | $179.48 | +17.00% | 88 | Jul 28, 2026 | |
| HCA HCA Healthcare | Maintained: Buy | $520 → $485 | $429.19 | +13.00% | 96 | Jul 27, 2026 | |
| CYH Community Health Systems | Maintained: Buy | $4 | $3.01 | +32.89% | 121 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $405 → $500 | $390.11 | +28.17% | 88 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $38.88 | +2.88% | 18 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $120.81 | +28.30% | 113 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $58 | $65.02 | -10.80% | 163 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $365 | $277.51 | +31.53% | 74 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $93.02 | n/a | 17 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.0003 | n/a | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $49.37 | n/a | 1 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $400.54 | n/a | 48 | Jun 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $0.045 | n/a | 6 | Aug 19, 2014 |
Healthcare Services Group
Aug 19, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $22.77
Upside: +22.97%
PACS Group
Aug 10, 2026
Maintained: Buy
Price Target: $48 → $57
Current: $44.25
Upside: +28.81%
Evolent Health
Aug 7, 2026
Rated: Buy
Price Target: $6
Current: $4.74
Upside: +26.58%
Guardian Pharmacy Services
Aug 7, 2026
Maintained: Buy
Price Target: $43 → $49
Current: $37.93
Upside: +29.19%
Teladoc Health
Aug 4, 2026
Rated: Buy
Price Target: $7
Current: $6.39
Upside: +9.55%
Chemed
Jul 31, 2026
Rated: Buy
Price Target: $500 → $590
Current: $540.57
Upside: +9.14%
Humana
Jul 30, 2026
Rated: Buy
Price Target: $260 → $405
Current: $378.88
Upside: +6.89%
The Ensign Group
Jul 28, 2026
Maintained: Buy
Price Target: $210
Current: $179.48
Upside: +17.00%
HCA Healthcare
Jul 27, 2026
Maintained: Buy
Price Target: $520 → $485
Current: $429.19
Upside: +13.00%
Community Health Systems
Jul 24, 2026
Maintained: Buy
Price Target: $4
Current: $3.01
Upside: +32.89%
Jul 17, 2026
Rated: Buy
Price Target: $405 → $500
Current: $390.11
Upside: +28.17%
May 8, 2026
Maintained: Buy
Price Target: $40
Current: $38.88
Upside: +2.88%
May 6, 2026
Rated: Buy
Price Target: $155
Current: $120.81
Upside: +28.30%
Apr 29, 2026
Rated: Buy
Price Target: $45 → $58
Current: $65.02
Upside: -10.80%
Oct 31, 2025
Maintained: Buy
Price Target: $365
Current: $277.51
Upside: +31.53%
Aug 9, 2024
Maintained: Hold
Price Target: n/a
Current: $93.02
Upside: n/a
Mar 2, 2023
Maintained: Buy
Price Target: $3
Current: $0.0003
Upside: n/a
Feb 9, 2018
Reiterated: Buy
Price Target: $35
Current: $49.37
Upside: n/a
Jun 7, 2017
Rated: Hold
Price Target: n/a
Current: $400.54
Upside: n/a
Aug 19, 2014
Rated: Buy
Price Target: $7
Current: $0.045
Upside: n/a